We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$131B
1-Year Est. Return
28.36%
This Fund
S&P 500
This Quarter
Est. Return
+25.27%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$80.5B
AUM Growth
+$14.9B
(+23%)
Cap. Flow
-$1.65B
Cap. Flow
% of AUM
-2.05%
Top 10 Holdings %
Top 10 Hldgs %
14.87%
Holding
1,659
New
136
Increased
550
Reduced
732
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$163M |
| 2 |
Chubb
CB
|
+$113M |
| 3 |
Accenture
ACN
|
+$107M |
| 4 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$99.7M |
| 5 |
Salesforce
CRM
|
+$96.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$121M |
| 2 |
Motorola Solutions
MSI
|
+$117M |
| 3 |
AGN
Allergan plc
AGN
|
+$116M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$91.7M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$83.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.81% |
| 2 | Financials | 13.12% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.18% |
Similar funds
DAM
Neuberger Berman Group's Q2 2020 Portfolio in Review
As of Q2 2020, Neuberger Berman Group held 1,659 positions worth $80.5B, up 23% from $65.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Neuberger Berman Group's Q2 2020 filing shows 136 new, 550 increased, 732 reduced and 126 closed positions. Its largest new stake was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M. The largest sale was Proofpoint, Inc., an estimated $121M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Neuberger Berman Group's largest Q2 2020 buy was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M.
- Neuberger Berman Group added most to TJX Companies in Q2 2020, an estimated $163M increase.
- Neuberger Berman Group's biggest Q2 2020 reduction was Proofpoint, Inc., cutting an estimated $121M.
- Neuberger Berman Group fully exited Allergan plc in Q2 2020, selling an estimated $116M.
- Neuberger Berman Group's ten largest holdings make up 15% of its $80.5B portfolio in Q2 2020.
- Neuberger Berman Group opened 136 new positions and closed 126 in Q2 2020.
- Neuberger Berman Group's portfolio value rose 23% quarter-over-quarter to $80.5B.
Based on Neuberger Berman Group's 13F filing for Q2 2020, filed 13 Aug 2020.